Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.
The next-generation sequencing-based test is designed to capture all clinically relevant cystic fibrosis mutations in a single assay.
Key market opportunities in the omics-based clinical trials sector include the rising adoption of personalized medicine, ...
Whole-genome sequencing (WGS) of tumor and germline can generate actionable molecular insights that can guide precision medicine efforts in salivary gland cancer (SGC), according to a new study in JCO ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
Leaders in microbiome science, clinical practice, and exotic animal medicine unite to advance next-generation diagnostics for ...
According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...
NeoGenomics’ third quarter results were met with a negative market reaction, as shares declined following the announcement. Management attributed the quarter’s performance to robust growth in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results